Intervention of Bladder Cancer by CAR-T

This study is testing a new immune cell therapy called CAR-T — where a patient's own immune cells are genetically engineered in a lab to find and destroy bladder cancer cells — for people with advanced or metastatic bladder cancer (including cancers of the urinary tract). **You may be eligible if...** - You have advanced or metastatic bladder or urinary tract cancer confirmed by tissue or lab test - Your cancer is measurable on imaging scans - You are in reasonably good health (able to carry out daily activities with minimal limitations) - Your blood counts and organ function are adequate - Your expected survival is at least 12 weeks **You may NOT be eligible if...** - You have received cancer treatment within the past 3 weeks - You are currently enrolled in another experimental treatment study - You are pregnant or breastfeeding - You have active autoimmune disease or serious infection Talk to your doctor to see if this trial is right for you.